The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 5.02
Ask: 6.30
Change: -0.10 (-1.96%)
Spread: 1.28 (25.498%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.10
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Scheme Convening Hearing

17 Jun 2022 16:27

RNS Number : 3594P
Nostrum Oil & Gas PLC
17 June 2022
 

 

 

FOR IMMEDIATE RELEASE

London, 17 June 2022

 

 

 

 

Proposed Scheme of Arrangement of the Company

 

Notice of Scheme Convening Hearing

 

Further to the announcement issued by Nostrum Oil & Gas PLC ("Nostrum", or "the Company") on 15 June 2022 regarding the anticipated date of the Scheme Convening Hearing, notice is hereby given that the Scheme Convening Hearing is scheduled take place before Mr Justice Meade in The Rolls Building, Court 11 at 2:00 pm BST on 20 June 2022 at the Business and Property Courts in the High Court of Justice of England and Wales.

 

At the Scheme Convening Hearing, the Company will seek an order granting it certain directions in relation to the Scheme, including permission to convene a meeting for the Scheme Creditors for the purpose of considering, and, if thought fit, approving the Scheme.

 

Any Scheme Creditor is entitled to attend the Scheme Convening Hearing to make representations to the Court, or to instruct counsel to attend the Scheme Convening Hearing and to make representations to the Court on his or her behalf.

 

Scheme Creditors who wish to attend the Scheme Convening Hearing, or who wish to instruct counsel to attend the Scheme Convening Hearing and to make representations to the Court on their behalf, should contact the Court or White & Case LLP (as the Company's co-counsel on the Scheme) by email to WCProjectNewport@whitecase.com specifying their name and email address, and if applicable, the name and email address of their counsel.

 

Capitalised terms used but not defined in this announcement have the meaning given to them in the Practice Statement Letter, which is available to the Scheme Creditors on the Scheme Portal (accessible via the Scheme Website at https://glas.agency/investor_reporting/nostrum-oil-gas-plc/).

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nog.co.uk

 

Further enquiries

Nostrum Oil & Gas PLC

Shane Drader - Chief Financial Officer

ir@nog.co.uk

 

GLAS Specialist Services Limited

Information Agent

lm@glas.agency

+44 20 3597 2940

 

Instinctif Partners - UK

Tim McCall

Sarah Hourahane

Galyna Kulachek

+ 44 (0) 207 457 2020

nostrum@instinctif.com

 

Notifying person

Thomas Hartnett

Company Secretary

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG) and the Kazakhstan Stock Exchange (ticker symbol: GB_NTRM). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field that is being operated by a wholly-owned subsidiary of Nostrum Oil & Gas PLC - Zhaikmunai LLP, who is the sole holder of the subsoil use rights with respect to the development of the field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGUBUVRUVUNAAR
Date   Source Headline
29th Apr 202212:38 pmRNSResults of General Meeting
29th Apr 20227:00 amRNSNotice of Revised Full Year Results Date
27th Apr 20224:40 pmRNSSecond Price Monitoring Extn
27th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:51 amRNSNotice of Revised Full Year Results Date
13th Apr 20221:46 pmRNSPublication of Circular/Notice of General Meeting
13th Apr 202210:25 amRNSProposed Restructuring & Related Party Transaction
8th Apr 20224:40 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20223:44 pmRNSRestatement of impairment charge in prior year
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
22nd Feb 20229:15 amRNSDirector Declaration
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:35 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSReceipt of Consents in respect of Solicitation
4th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSOperational Update for 4Q and FY2021
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20221:46 pmRNSConsent Solicitation relating to Senior Notes
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20225:36 pmRNSRelated Party Transaction update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 202212:26 pmRNSUpdate on accessions to lock-up agreement
5th Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:59 pmRNSLock-up agreement and restructuring terms
21st Dec 20217:00 amRNSStatement regarding recent media speculation
17th Dec 20211:00 pmRNSExtension of Forbearance Agreement
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:35 pmRNSPrice Monitoring Extension
6th Dec 202111:45 amRNSExtension of Forbearance Agreement
6th Dec 20218:36 amRNSTR-1: Notification of major holdings
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20219:00 amRNSExtension of Forbearance Agreement
23rd Nov 20219:00 amRNSRE AGM vote on authorisation to allot shares
16th Nov 20217:00 amRNS9M 2021 Financial Results
9th Nov 20219:00 amRNSExtension of Forbearance Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.